Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership. This heritage has given us experience and capabilities that enable us to help people defeat serious chronic conditions: Diabetes, haemophilia, growth disorders and obesity. Novo Nordisk was founded more than 90 years ago. This includes three decades of improving lives of people with haemophilia through support to improved diagnosis, treatment and care. Headquartered in Denmark, Novo Nordisk employs approximately 42,100 people in 79 countries and markets its products in more than 170 countries.